These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22010781)

  • 1. Case reports of sarcoma patients with optimized lectin-oriented mistletoe extract therapy.
    Kirsch A; Hajto T
    J Altern Complement Med; 2011 Oct; 17(10):973-9. PubMed ID: 22010781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
    Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
    Arzneimittelforschung; 2004; 54(8):456-66. PubMed ID: 15460213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of antibodies to the chitin-binding mistletoe lectin (cbML) in tumor patients before and during therapy with an aqueous mistletoe extract.
    Klein R; Franz M; Wacker R; Classen K; Scheer R; Von Laue HB; Stoeva S; Voelter W
    Eur J Med Res; 2004 Jun; 9(6):316-22. PubMed ID: 15257874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
    Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
    Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mistletoe lectin is not the only cytotoxic component in fermented preparations of Viscum album from white fir (Abies pectinata).
    Eggenschwiler J; von Balthazar L; Stritt B; Pruntsch D; Ramos M; Urech K; Rist L; Simões-Wüst AP; Viviani A
    BMC Complement Altern Med; 2007 May; 7():14. PubMed ID: 17493268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptomic and proteomic insight into the effects of a defined European mistletoe extract in Ewing sarcoma cells reveals cellular stress responses.
    Twardziok M; Meierhofer D; Börno S; Timmermann B; Jäger S; Boral S; Eggert A; Delebinski CI; Seifert G
    BMC Complement Altern Med; 2017 Apr; 17(1):237. PubMed ID: 28454538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mistletoe (Viscum album) preparations: an optional drug for cancer patients?].
    Bar-Sela G; Gershony A; Haim N
    Harefuah; 2006 Jan; 145(1):42-6, 77. PubMed ID: 16450726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrolective, comparative, epidemiological cohort study with parallel groups design for evaluation of efficacy and safety of drugs with "well-established use".
    Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
    Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():23-9. PubMed ID: 15353899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Mistletoe Triterpene Acids on the Uptake of Mistletoe Lectin by Cultured Tumor Cells.
    Mulsow K; Enzlein T; Delebinski C; Jaeger S; Seifert G; Melzig MF
    PLoS One; 2016; 11(4):e0153825. PubMed ID: 27088729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-12 is associated with the in vivo anti-tumor effect of mistletoe extracts in B16 mouse melanoma.
    Duong Van Huyen JP; Delignat S; Bayry J; Kazatchkine MD; Bruneval P; Nicoletti A; Kaveri SV
    Cancer Lett; 2006 Nov; 243(1):32-7. PubMed ID: 16412563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological response to mistletoe (Viscum album L.) in cancer patients: a four-case series.
    Gardin NE
    Phytother Res; 2009 Mar; 23(3):407-11. PubMed ID: 19003944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on local inflammatory reactions and other parameters during subcutaneous mistletoe application in HIV-positive patients and HIV-negative subjects over a period of 18 weeks.
    Stoss M; van Wely M; Musielsky H; Gorter RW
    Arzneimittelforschung; 1999 Apr; 49(4):366-73. PubMed ID: 10337457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mistletoe (viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy. A review.
    Bocci V
    J Biol Regul Homeost Agents; 1993; 7(1):1-6. PubMed ID: 8346712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paediatric medulloblastoma cells are susceptible to Viscum album (Mistletoe) preparations.
    Zuzak TJ; Rist L; Eggenschwiler J; Grotzer MA; Viviani A
    Anticancer Res; 2006; 26(5A):3485-92. PubMed ID: 17094471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a mistletoe preparation with defined lectin content on chronic hepatitis C: an individually controlled cohort study.
    Huber R; Lüdtke R; Klassen M; Müller-Buscher G; Wolff-Vorbeck G; Scheer R
    Eur J Med Res; 2001 Sep; 6(9):399-405. PubMed ID: 11669085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ingredients of mistletoe (Viscum album L.) as potential drugs].
    Franz H
    Pharmazie; 1985 Feb; 40(2):97-104. PubMed ID: 3889937
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiproliferative and anticarcinogenic effects of an aqueous preparation of Abies alba and Viscum album se abies, on a L-1210 malignant cell line and tumor-bearing Wistar rats.
    Karkabounas S; Assimakopoulos D; Malamas M; Skaltsounis AL; Leonce S; Zelovitis J; Stefanou D; Evangelou A
    Anticancer Res; 2000; 20(6B):4391-5. PubMed ID: 11205277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of the Korean mistletoe lectin is attributed to activation of macrophages and NK cells.
    Yoon TJ; Yoo YC; Kang TB; Song SK; Lee KB; Her E; Song KS; Kim JB
    Arch Pharm Res; 2003 Oct; 26(10):861-7. PubMed ID: 14609136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in breast cancer patients during chemotherapy and concurrent therapy with a mistletoe extract.
    Eisenbraun J; Scheer R; Kröz M; Schad F; Huber R
    Phytomedicine; 2011 Jan; 18(2-3):151-7. PubMed ID: 20724129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of antibodies to viscotoxins A1, A2, A3, and B in tumour patients during therapy with an aqueous mistletoe extract.
    Klein R; Classen K; Fischer S; Errenst M; Scheffler A; Stein GM; Scheer R; von Laue HB
    Eur J Med Res; 2002 Aug; 7(8):359-67. PubMed ID: 12204844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.